Levodopa Inhalation Powder, with the English name levodopa, is an innovative treatment option for "off" episodes in patients with Parkinson's disease. Its price, purchasing methods, and storage conditions are of great significance for patients' medication use. Currently, this drug has not been launched in China and is not covered by medical insurance. The original drug produced by Acorda Therapeutics, Inc. is priced at $686 per box (33mg * 60 capsules).
Price Overview of Levodopa Inhalation Powder in 2025
Levodopa Inhalation Powder is a new-type preparation in the field of Parkinson's disease treatment. Its price is affected by factors such as R&D costs, production processes, and market supply and demand. The latest price information in 2025 shows that although the price of this drug is relatively high, its clinical value is significant.
Original Drug Price
In 2025, the price of Inbrija (Levodopa Inhalation Powder) produced by Acorda Therapeutics, Inc. is $686 per box, with a specification of 33mg * 60 capsules. This price reflects the R&D costs and patent protection value of the innovative inhalation preparation. The above price is for reference only, and the specific price shall be subject to the actual situation.
Regional Price Differences
Since this drug has not been launched in China, domestic patients need to import it through special channels if they need to use it, which may incur additional costs. The retail price in the U.S. market is approximately $650 - $720 per box, and the price in some parts of Europe may be 5 - 10% lower. Understanding the drug price information helps patients make treatment budgets, and we also look forward to the early launch of this drug in China and its inclusion in medical insurance.
How to Purchase Levodopa Inhalation Powder
As Levodopa Inhalation Powder has not been launched in China, patients need to purchase it through special channels. Choosing formal channels is crucial to ensuring the quality of the drug.
Assistance from International Medical Institutions
Neurology departments of hospitals with international referral qualifications can assist patients in obtaining the drug. This method requires providing complete medical records and prescriptions, and the procurement process usually takes 3 - 4 weeks to complete.
Direct Purchase from Overseas Pharmacies
Pharmacies in regions such as the United States and the European Union sell the drug with a prescription. It is recommended to choose large chain pharmacies and confirm the integrity of the drug packaging and the validity period. Special attention should be paid to the temperature and humidity control during transportation when purchasing.
Procurement by Medical Institutions
Medical institutions usually establish stable cooperative relationships with drug suppliers, enabling them to purchase high-quality and reliable drugs at lower prices. In addition, medical institutions can also provide professional medication guidance and consultation services to help patients use Levodopa Inhalation Powder better.
How to Store Levodopa Inhalation Powder
Levodopa Inhalation Powder has strict requirements on storage conditions, and the correct storage method directly affects the stability of the drug and the therapeutic effect.
Storage of Unopened Drugs
The drug should be stored in its original packaging in a dry environment at 20℃ - 25℃, avoiding direct sunlight and moisture. Capsules in aluminum foil packaging must not be taken out before use to prevent moisture and invalidation.
Handling of Opened Products
After the inhaler is opened, it should be used up within 1 month. Clean the inhaler after each use and store it in a dry and clean environment. Capsules that have been taken out but not used should be discarded and must not be put back into the packaging.
Strictly abiding by the storage requirements can ensure the therapeutic effect of the drug. Patients should regularly check the appearance and validity period of the drug.
